Exelixis
EXEL
#1659
Rank
S$13.75 B
Marketcap
$48.16
Share price
1.26%
Change (1 day)
68.51%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Exelixis (EXEL) - Cost to borrow shares

Latest borrow fee for Exelixis (EXEL) shares on Interactive Brokers: 0.2500% (annualized)

Shares available to borrow: 9500000

The cost to borrow / borrow fee is an annualized percentage an account is charged when borrowing shares of a stock.
Please note that the borrow fee and available shares to borrow displayed on this page are solely based on information provided by Interactive Brokers.

Exelixis (EXEL) - cost to borrow in the last 7 days chart

Exelixis (EXEL) - number of shares available to borrow in the last 7 days

Exelixis (EXEL) - cost to borrow from 2024 to 2023

Exelixis (EXEL) - number of shares available to borrow from 2024 to 2023

Cost to borrow for shares of similar companies or competitors

Company Cost to borrow (% year) Shares available Country
0.4974%0.65 M๐Ÿ‡ฌ๐Ÿ‡ง UK
0.419%3.2 M๐Ÿ‡ซ๐Ÿ‡ท France
0.3841%10 M๐Ÿ‡บ๐Ÿ‡ธ USA
0.25%10 M๐Ÿ‡บ๐Ÿ‡ธ USA
0.4038%5.8 M๐Ÿ‡บ๐Ÿ‡ธ USA
0.3896%10 M๐Ÿ‡บ๐Ÿ‡ธ USA
0.4027%10 M๐Ÿ‡บ๐Ÿ‡ธ USA
3.5911%0.8 M๐Ÿ‡บ๐Ÿ‡ธ USA